Trial · NCT07877181
Vibrating and Non-Vibrating Foam-Rolling on DOMS
NCT07877181, Not applicable, Completed, Hacettepe University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Vibrating and Non-Vibrating Foam-Rolling on DOMS. Trials, record NCT07877181. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877181
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Vibrating and Non-Vibrating Foam-Rolling on DOMS
- NCT number
- NCT07877181
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 30 participants, actual
- Lead sponsor
- Hacettepe University
- Conditions
- Delayed Onset Muscle Soreness (DOMS)
- Interventions
- Vibrating Foam Rolling, Non-Vibrating Foam Rolling
- First posted
- 2026-10-16
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Ankle Dorsiflexion Range of Motion | Baseline, 48 hours after DOMS induction, and immediately after foam rolling | Ankle dorsiflexion range of motion was assessed using the Weight-Bearing Lunge Test. Participants moved the tested knee toward the wall while maintaining heel contact. The maximum distance between the great toe and the wall was recorded in centimeters. Three measurements were performed for each lower extremity and the mean value was used for analysis. |
| Primary | Dynamic Balance | Baseline, 48 hours after DOMS induction, and immediately after foam rolling | Dynamic balance was assessed using the Y-Balance Test. Participants performed maximal reaches in the anterior, posteromedial, and posterolateral directions while maintaining single-leg stance. Each direction was measured three times and the mean reach distance was recorded. Reach distances were normalized to lower-extremity length. |
| Secondary | Gastrocnemius Muscle Strength | Baseline, 48 hours after DOMS induction, and immediately after foam rolling | Isometric gastrocnemius muscle strength was assessed using a KForce hand dynamometer. Participants were positioned prone with the knee fully extended and the ankle in a neutral position. Three measurements were obtained for each lower extremity and the mean value was used for analysis. |
| Secondary | Gastrocnemius Muscle Mechanical Properties | Baseline, 48 hours after DOMS induction, and immediately after foam rolling | Passive mechanical properties of the medial and lateral gastrocnemius muscles, including muscle tone, stiffness, and elasticity, were assessed using a Myoton-3 myotonometric device. Measurements were obtained from standardized anatomical locations with the participant in the prone position, the knees fully extended, and the ankles relaxed. Ten consecutive measurements were obtained from each measurement site and averaged for analysis. |
| Secondary | Pain | Baseline, 48 hours after DOMS induction, and immediately after foam rolling | Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) during standardized gastrocnemius stretching. Participants rated their pain intensity on a continuous scale ranging from 0 cm (no pain) to 10 cm (worst imaginable pain). Higher values indicate greater pain intensity. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07877181
GET https://conductscience.org/api/trials/v1/NCT07877181/registered